Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Malignancies × Furosemide × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pre-Eclampsia 1 Parkinson Disease 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Lymphoma, Follicular 1 Liver Cirrhosis 1 Lewy Body Disease 1 Congenital Hyperinsulinism 1 Brain Neoplasms 1 Advanced Solid Malignancies 1

Interventions

atezolizumab 1 Tiragolumab 1 Rosuvastatin Calcium 1 Radiotherapy 1 Rabeprazole 1 Metformin 1 Injections 1 Furosemide 1 Digoxin 1 ATP Binding Cassette Transporter, Subfamily B, Member 1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06899061 2026-03-03

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

AstraZeneca

Phase 1 Active not recruiting

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡